clinical trial · NCT00650000
Fasting Study of Modafinil Tablets 200 mg and Provigil® Tablets 200 mg
HealthyModafinil Tablets 200 mgProvigil® Tablets 200 mg
brief summary
The objective of this study was to investigate the bioequivalence of Mylan modafinil 200 mg tablets to Cephalon Provigil® 200 mg tablets following a single, oral 200 mg (1 x 200 mg) dose administration under fasting conditions.
started
Oct 1, 2002
primary completion
Oct 1, 2002
completion
Oct 1, 2002
last updated
Apr 24, 2024
official title
Single-Dose Fasting In Vivo Bioequivalence Study of Modafinil Tablets (200 mg; Mylan) and Provigil® Tablets (200 mg; Cephalon) in Healthy Volunteers
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol